» Articles » PMID: 39853480

Acute Effects of Beetroot Extract and Resveratrol Ingestion on Cardiovascular and Cardiac Autonomic Modulation Recovery After Moderate-intensity Aerobic Exercise in Individuals with Coronary Artery Disease: a Triple-blinded, Randomized,...

Overview
Journal Eur J Nutr
Date 2025 Jan 24
PMID 39853480
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aimed to evaluate the acute effects of beetroot extract and resveratrol supplementation (isolated and combined) on cardiac autonomic modulation and cardiovascular parameters recovery after exercise in individuals with coronary artery disease (CAD).

Methods: 14 males with CAD were submitted to 4 protocols consisting of 30 min (min) of rest, 30 min of aerobic exercise on a treadmill (60% of the heart rate reserve HRR), followed by 30 min of recovery. Before each protocol, the subjects consumed 500 mg of starch (placebo protocol), 500 mg of beetroot (beetroot protocol), or 500 mg of resveratrol (resveratrol protocol), or 500 mg of beetroot and 500 mg of resveratrol (combined protocol). Heart rate variability (HRV) indices and cardiorespiratory parameters were determined at different times during the protocols.

Results: Regarding HR, significantly higher values about rest in the placebo protocol at all recovery moments (1st to 30th min) were observed. Significant differences were observed in the other protocols (beetroot, resveratrol and combined) from the first to the 20th min recovery. For SBP, significantly higher values concerning rest were observed at the first minute of recovery for all protocols. No differences were found for the HRV index between time and protocols.

Conclusions: The single supplementation of beetroot and resveratrol (isolated and combined) did not alter HRV and cardiovascular parameter responses between protocols. The consumption of beetroot extract and resveratrol enhanced vagal modulation and heart rate recovery compared to rest.

References
1.
Lindstrom M, DeCleene N, Dorsey H, Fuster V, Johnson C, LeGrand K . Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021. J Am Coll Cardiol. 2022; 80(25):2372-2425. DOI: 10.1016/j.jacc.2022.11.001. View

2.
Alvarez-Alvarez M, Zanetti D, Carreras-Torres R, Moral P, Athanasiadis G . A survey of sub-Saharan gene flow into the Mediterranean at risk loci for coronary artery disease. Eur J Hum Genet. 2017; 25(4):472-476. PMC: 5386420. DOI: 10.1038/ejhg.2016.200. View

3.
Santos R . [III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia]. Arq Bras Cardiol. 2002; 77 Suppl 3:1-48. View

4.
Pedersen T, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G . Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl. 2004; 5(3):81-7. DOI: 10.1016/j.atherosclerosissup.2004.08.027. View

5.
Morris J, CHAVE S, Adam C, Sirey C, Epstein L, Sheehan D . Vigorous exercise in leisure-time and the incidence of coronary heart-disease. Lancet. 1973; 1(7799):333-9. DOI: 10.1016/s0140-6736(73)90128-1. View